New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization The Biotechnology Innovation Organization (BIO) today announced BIOEquality Agenda which aims to attack the systemic inequality, injustice and unfair treatment of women and communities of color through the positive force of biotechnology. Recognizing that gains from transformative science are not always shared equally, BIO is challenging the industry, and its partners, to find solutions for inequitable healthcare delivery, disparate economic development and nutritional and environmental disparities in the US and around the globe. BIOEquality Agenda revolves around three pillars of change that will support stronger and healthier communities: Promote Health Equity Enhance clinical trial diversity by partnering with Contract Research Organizations and Minority Serving Institutions Promote access to vaccines and therapeutics for uninsured and underserved populations, especially related to COVID Foster enhanced nutritional, environmental, and mental wellness opportunities in economically disadvantaged communities   Invest in the Current and Next Generation of Scientists Inventory and promote visibility of industry-sponsored minority training programs Establish STEM training best practices for underrepresented populations Create a network of minority scientists and engineers   Facilitate a partnering network, including hiring of industry-trained minority scientists and engineers   Expand Opportunity for Women and Other Underrepresented Populations Enhance use of minority- and women owned small businesses in biotech supply chains, to promote economic development of marginalized communities and especially those, hard hit by COVID-19 Promote diversity of the NIH SBIR Grants Dr. Michelle McMurry-Heath who…